直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
Cora R. Holt
Partner
More
vCard
  • 901 New York Avenue, NW
  • Washington, DC 20001-4413
+1 202 408 4334
cora.holt@finnegan.com cora.holt@finnegan.com

Cora R. Holt

Partner

  • +1 202 408 4334 +1 202 408 4334
  • cora.holt@finnegan.com cora.holt@finnegan.com
  • 901 New York Avenue, NW
  • Washington, DC 20001-4413
  • vCard

Cora Holt is an experienced patent litigator at both the trial and appellate levels. A former clerk at the U.S. Court of Appeals for the Federal Circuit, Cora represents clients in patent disputes in district courts across the country, the International Trade Commission (ITC), the Federal Circuit, the U.S. Supreme Court, and the U.S. Patent and Trademark Office (USPTO).

Cora handles cases involving a variety of technologies, with an emphasis on the biotechnology, pharmaceutical, and life sciences industries, including Hatch-Waxman and biologics cases. She has represented clients in cases involving small and large molecules, medical devices, human therapeutic antibodies, gene therapies, drug delivery systems, soybean plants, and engineered microorganisms, to name a few. Her experience spans all aspects of patent litigation, including pre-suit diligence, case strategy, fact and expert discovery, dispositive motions and briefs, pretrial and trial submissions, preparing and examining witnesses at trial, and presenting argument before trial and appellate courts.

In addition to her litigation work, Cora assists clients in portfolio counseling matters and proceedings before the USPTO. She has been recognized as a “Rising Star”, an “IP Star”, and a notable practitioner on the national level by Managing Intellectual Property (MIP) and named to the Best Lawyers 2021 Ones to Watch list. Cora also devotes significant time to pro bono work, particularly the representation of veterans in cases before the Federal Circuit, the U.S. Court of Appeals for Veterans Claims, and the U.S. Court of Federal Claims.

Cora serves as the hiring partner for Finnegan’s Washington, D.C. office.

Et Cetera

  • Co-recipient, George Hutchinson Committee Award, Federal Circuit Bar Association® Bench & Bar® Conference, 2022. 
  • Capital Pro Bono High Honor Roll, 2018; Honor Roll, 2017-2019.
  • Clerked for the Honorable Chief Judge Sharon Prost in the U.S. Court of Appeals for the Federal Circuit, 2015-2016.
  • Interned for the Honorable Chief Judge William M. Conley in the U.S. District Court for the Western District of Wisconsin, 2010.

Experience

Genzyme Corporation et al. v. Novartis Gene Therapies, Inc. et al.

Successfully defended Novartis against Genzyme’s multiple patent infringement actions and inter partes review (IPR) proceedings related to recombinant adeno-associated virus vector technology used in Novartis’ blockbuster, breakthrough gene therapy Zolgensma®. The case settled after four patents were invalidated during claim construction, five patents found not literally infringed, and institution of multiple IPRs.

1:21-cv-01736, 1:23-cv-00554, D. Del., Judge Andrews

Abbott Biotechnology Ltd. v. Centocor Ortho Biotech Inc.

Represented AbbVie in a validity and infringement dispute involving Humira® (human therapeutic antibodies), one of the best selling drugs in the world. The case settled favorably.

4:09-cv-40089, D. Mass., Judge Saylor

Abbvie Inc. v. The Mathilda and Terence Kennedy Institute of Rheumatology Trust

Represented plaintiff in two declaratory judgment cases, successfully invalidating patents either by trial or summary judgment; both were affirmed on appeal.

1:11-cv-02541; 1:13-cv-01358, S.D.N.Y., Judge Crotty
13-1545; 14-1672, Fed. Cir., Judges Chen, Dyk, Wallach, Taranto

In re Fetzima

Representing Allergan and Pierre Fabre in ANDA litigation in the District of New Jersey against multiple generic drug manufacturers seeking to make a generic version of Fetzima® (levomilnacipran) for the treatment of major depressive disorder.

2:17-cv-10230, D.N.J., Judges Mannion, Salas

Ajinomoto Co., Inc. et al. v. CJ Cheiljedang Corp. et al.

Represented Ajinomoto in the Southern District of New York in litigation involving patents related to genetically modified organisms and the use thereof to make commercial quantities of tryptophan. This representation follows successful representation of Ajinomoto in related IPR proceedings, ITC investigation, and subsequent Federal Circuit appeal.

1:16-cv-03498, S.D.N.Y., Judges Gorenstein, Vyskocil
337-TA-1005, ITC, Judges Bullock, Essex
18-1590, -1629, Fed. Cir., Judges Dyk, Moore, Taranto
IPR2017-01551, -01698, PTAB, Judges Franklin, Mitchell, Moore, Sawert, Yang

American Regent, Inc. v. Pharmacosmos Therapeutics Inc. et al.

Counsel for American Regent in litigation in the District of New Jersey against Pharmacosmos and their branded drug, Monoferric®, related to American Regent patents covering the use of iron carbohydrate complexes for the treatment of iron deficiency diseases. The case resulted in a favorable settlement for our client.

PGR2020-00009, PTAB, Judges Tornquist, Franklin, Wisz
3:20-cv-01350, D.N.J., Judges Goodman, Martinotti, Quraishi

More

Insights

Charitable

2024 AIPLA Women in IP DC Community Service Event

2024 AIPLA Women in IP DC Community Service Event 2024 AIPLA Women in IP DC Community Service Event

January 23, 2024

Washington

Webinar

Patent Infringement, Safe Harbor, and Drug Development: Navigating the Uncertain Boundaries, Recent Court Treatment Patent Infringement, Safe Harbor, and Drug Development: Navigating the Uncertain Boundaries, Recent Court Treatment

November 30 2023

Webinar

Podcasts

October 2023 - Last Month at the Federal Circuit Podcast Series

October 2023 - Last Month at the Federal Circuit Podcast Series October 2023 - Last Month at the Federal Circuit Podcast Series

November 2, 2023

Download

Federal Circuit IP Blog

Podcast Series: Last Month at the Federal Circuit - October 2023 Podcast Series: Last Month at the Federal Circuit - October 2023

November 2, 2023

Download

Webinar

Inducement in a Pharmaceutical, Post-Launch Non-Hatch-Waxman World Inducement in a Pharmaceutical, Post-Launch Non-Hatch-Waxman World

July 6, 2023

Webinar

Webinar

Billion Dollar Patents: Building a Strong Patent Portfolio, Generating Value, Protecting IP Billion Dollar Patents: Building a Strong Patent Portfolio, Generating Value, Protecting IP

September 8, 2022

Webinar

More

News

Award/Ranking

61 Finnegan Attorneys Recognized on the 2025 Capital Pro Bono Honor Roll 61 Finnegan Attorneys Recognized on the 2025 Capital Pro Bono Honor Roll

May 7, 2026

Commentary

She Has a Point: Finnegan's Cora Holt She Has a Point: Finnegan's Cora Holt

March 13, 2026

Law360

Announcement

Finnegan Announces 2025 Mentors of the Year Finnegan Announces 2025 Mentors of the Year

December 19, 2025

Press Release

Pro Bono: Finnegan Obtains Dismissal of Homicide and Related Charges Against DC Man Pro Bono: Finnegan Obtains Dismissal of Homicide and Related Charges Against DC Man

June 13, 2025

Award/Ranking

Finnegan Remains a Top Tier Firm in the 2025 Managing Intellectual Property IP Stars Rankings

Finnegan Remains a Top Tier Firm in the 2025 Managing Intellectual Property IP Stars Rankings

May 30, 2025

Managing Intellectual Property

Award/Ranking

Finnegan Ranks at the Top of the Managing Intellectual Property IP Stars Rankings Finnegan Ranks at the Top of the Managing Intellectual Property IP Stars Rankings

June 28, 2024

Managing Intellectual Property
More

Professional Activities

  • American Bar Association
  • American Intellectual Property Law Association
  • ChIPs: Advancing Women in IP
  • Federal Circuit Bar Association
    (Chair, 2023-present and Vice-chair, 2020-2023, Next Gen Committee)
Admissions and Education

Admissions

  • U.S. Patent and Trademark Office
  • District of Columbia
  • Wisconsin
  • Virginia
  • Supreme Court of the United States
  • U.S. Court of Appeals, Federal Circuit
  • U.S. Court of Federal Claims
  • U.S. Court of Appeals, Veterans Claims

Education

University of Wisconsin Law School
J.D., 2011
University of Wisconsin, Madison
B.S., Biochemistry and Agricultural Journalism, 2008

Clerkships

  • U.S. Court of Appeals, Federal Circuit, Hon. Sharon Prost

Cora's Practices

Diligence, Licensing, and Opinions
Due Diligence
Licensing, Pooling, and Other Transactions
Opinions and Counseling
Global IP Enforcement, Litigation, and Trials
Branded Hatch-Waxman (ANDA) Litigation and Trials
Federal Circuit and Supreme Court Appeals
ITC Section 337 Investigations and Trials
Patent Litigation and Trials
Pretrial Strategies
Patent Office Invalidation Proceedings
PTAB Invalidation Proceedings: IPR and PGR
Prosecution and Portfolio Management
IP Portfolio Management

Cora's Industries

Chemicals, Industrials, and Materials
Chemical
Hospitality, Gaming, and Leisure
Sports, Fitness, and Outdoor Recreation
Life Sciences
Biologics
Biotechnology
Pharmaceutical

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP